TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated November 28, 1975